Abstract:Gastric cancer (GC) is the fifth most common cancer and GC has a high mortality rate worldwide. Circular (circ) RNAs serve an important role in cancer. The present study aimed to investigate the expression level of hsa_circ_0060975 in gastric cancer (GC) and to determine the clinical pathological significance of hsa_circ_0060975 in patients with GC. Reverse transcription-quantitative PCR was used to detect expression level of hsa_circ_0060975 in 192 GC and adjacent non-cancerous gastric tissues, in GC cell lines (MKN-45, HGC27 and AGS) and a human gastric epithelium cell line (GES-1), as well as in plasma samples from 126 patients with GC and 92 healthy volunteers. All plasma and tissue samples of were obtained from The First Affiliated Hospital of Anhui Medical University (Hefei, China). The relationship between hsa_circ_0060975 expression and clinical pathological factors was analyzed using the χ2 test. The diagnostic value of hsa_circ_0060975 was analyzed using the receiver operating characteristic curve (ROC curve), while the Kaplan-Meier method was used to analyze the relationship of hsa_circ_0060975 expression with the survival of patients with GC as determined by log-rank tests. Univariate and multivariate Cox regression analyses were used to identify the prognostic factors, including hsa_circ_0060975 expression and clinical pathological factors. In addition, the potential function of hsa_circ_0060975 was evaluated via bioinformatics analysis. The expression level of hsa_circ_0060975 was higher in GC tissues compared with adjacent non-cancerous gastric tissues, GC cell lines compared with GES-1 and plasma samples from patients with GC compared with plasma samples from healthy volunteers. In addition, higher hsa_circ_0060975 expression was associated with histological grade, pathological stage and tumor (T) classification in GC tissues and plasma samples (P<0.05). The area under the ROC curves of hsa_circ_0060975, the combination with hsa_circ_0060975 and carcinoembryonic antigen (CEA) or CEA alone were 0.804 (sensitivity, 0.746; specificity, 0.783; P<0.001); 0.931 (sensitivity, 0.937; specificity, 0.870; P<0.001) and 0.924 (sensitivity, 0.937; sspecificity, 0.804; P<0.001) respectively. The Kaplan-Meier survival analysis revealed that the overall survival (OS) and disease-free survival (DFS) time of patients with higher hsa_circ_0060975 expression were shorter compared with those in patients with lower hsa_circ_0060975 expression. Univariate and multivariate Cox regression analyses in OS and DFS time determined that the expression level of hsa_circ_0060975, histological grade and pathological stage were independent prognostic factors for patients with GC. In addition, the bioinformatics analysis results suggested that the abnormal expression of hsa_circ_0060975 may serve an important role in tumorigenesis. Hence, hsa_circ_0060975 expression may be an independent prognostic factor for patients with GC and may be a potential marker for biological malignancy.

Low Expression of Circular RNA Hsa_circ_0078607 Predicts Poor Prognosis in High-Grade Serous Ovarian Cancer.

Low expression of circular RNA hsa_circ_0078607 predicts poor prognosis in high-grade serous ovarian cancer

Circular RNAs and Their Emerging Roles As Diagnostic and Prognostic Biomarkers in Ovarian Cancer

Hsa_Circ_0066351 Acts as a Prognostic and Immunotherapeutic Biomarker in Colorectal Cancer

Hsa_circ_0060975 is Highly Expressed and Predicts a Poor Prognosis in Gastric Cancer

Down-regulation of Hsa_circ_0001649 in Hepatocellular Carcinoma Predicts a Poor Prognosis

Decreased Expression of Hsa_circ_0072387 As a Valuable Predictor for Oral Squamous Cell Carcinoma

Down-regulation of Hsa_circ_0092125 is Related to the Occurrence and Development of Oral Squamous Cell Carcinoma

Comprehensive Assessment of Serum hsa_circ_0070354 as a Novel Diagnostic and Predictive Biomarker in Non-small Cell Lung Cancer

Circular RNA profiling and its potential for esophageal squamous cell cancer diagnosis and prognosis

Up-Regulation of Hsa_circ_0000517 Predicts Adverse Prognosis of Hepatocellular Carcinoma.

Clinical Significance of the Decreased Expression of Hsa_circ_001242 in Oral Squamous Cell Carcinoma

Circular RNA hsa_circ_0078607 suppresses ovarian cancer progression by regulating miR-518a-5p/Fas signaling pathway

Profiling and Bioinformatics Analyses Reveal Differential Circular RNA Expression in Ovarian Cancer

The expression profile and clinical application value of hsa_circ_0016148 in head and neck squamous cell carcinoma

Circ_0004771 regulates malignant biological behaviors and has clinical significance in oral squamous cell carcinoma

Upregulation of hsa_circRNA_102958 Indicates Poor Prognosis and Promotes Ovarian Cancer Progression Through miR-1205/SH2D3A Axis

Hsa_circ_0000467 Promotes Cancer Progression and Serves As a Diagnostic and Prognostic Biomarker for Gastric Cancer

Circ_0070203 Promotes Epithelial-mesenchymal Transition in Ovarian Serous Cystadenocarcinoma through miR-370-3p/TGFβR2 Axis

Prognostic Value of Circular RNA ciRS-7 in Various Cancers: A PRISMA-Compliant Meta-Analysis

Hsa_circ_0001020 Serves as a Potential Biomarker for Gastric Cancer Screening and Prognosis